April 13, 2017 / 3:52 PM / 4 months ago

BRIEF-Recordati Rare Diseases buys North American marketing rights to Cystadane

April 13 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA:

* Recordati Rare Diseases Inc. acquires North American marketing rights to Cystadane (betaine anhydrous for oral solution) Source text: www.1info.it Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below